Showing 1 to 3 of 3 results


French Court Awards €325,000 for Androcur's Failure to Warn of Meningioma Risk
A French court ordered Bayer, Viatris, and Sandoz to pay €325,000 to a woman who developed meningiomas after taking Androcur for over 20 years due to their failure to adequately warn her about this risk, a ruling that could affect future legal actions.
French Court Awards €325,000 for Androcur's Failure to Warn of Meningioma Risk
A French court ordered Bayer, Viatris, and Sandoz to pay €325,000 to a woman who developed meningiomas after taking Androcur for over 20 years due to their failure to adequately warn her about this risk, a ruling that could affect future legal actions.
Progress
40% Bias Score


\$7.4 Billion Settlement Reached in Purdue Pharma Opioid Lawsuits
Purdue Pharma and the Sackler family agreed to pay up to \$7.4 billion to settle lawsuits over the opioid crisis caused by OxyContin, exceeding a prior rejected settlement by more than \$1 billion; the Sacklers will contribute up to \$6.5 billion, Purdue \$900 million, and the funds will compensate ...
\$7.4 Billion Settlement Reached in Purdue Pharma Opioid Lawsuits
Purdue Pharma and the Sackler family agreed to pay up to \$7.4 billion to settle lawsuits over the opioid crisis caused by OxyContin, exceeding a prior rejected settlement by more than \$1 billion; the Sacklers will contribute up to \$6.5 billion, Purdue \$900 million, and the funds will compensate ...
Progress
44% Bias Score

Walgreens to Pay Up to $350 Million in Opioid Prescription Settlement
Walgreens agreed to pay up to $350 million to settle a U.S. Department of Justice lawsuit alleging it illegally filled millions of opioid prescriptions from 2012-2023, despite internal red flags; the company denies liability but says the settlement improves cash flow.

Walgreens to Pay Up to $350 Million in Opioid Prescription Settlement
Walgreens agreed to pay up to $350 million to settle a U.S. Department of Justice lawsuit alleging it illegally filled millions of opioid prescriptions from 2012-2023, despite internal red flags; the company denies liability but says the settlement improves cash flow.
Progress
40% Bias Score
Showing 1 to 3 of 3 results